CSIMarket


Amphastar Pharmaceuticals Inc   (AMPH)
Other Ticker:  
 

Amphastar Pharmaceuticals Inc

AMPH's Fundamental analysis








Looking into Amphastar Pharmaceuticals Inc growth rates, revenue grew by 27.26 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 363

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.32 %

Amphastar Pharmaceuticals Inc 's net income grew by 27.32 % in I. Quarter 2024 year on year, above company average,

More on AMPH's Growth


Amphastar Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Amphastar Pharmaceuticals Inc PEG ratio is at 0.28 Company is currently trading with Price to Cash flow multiple of 13.37 in trailing twelve-month period.
Company
15.96
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.59.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.


More on AMPH's Valuation
 
 Total Debt (Millions $) 594
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 297,356
 Net Income/Employee (TTM) $ 67,360
 Receivable Turnover (TTM) 5.52
 Tangible Book Value (Per Share $) 1.23

Amphastar Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Amphastar Pharmaceuticals Inc PEG ratio is at 0.28 Company is currently trading with Price to Cash flow multiple of 13.37 in trailing twelve-month period.
Company
15.96
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.59.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.

Amphastar Pharmaceuticals Inc Price to Book Ratio is at 3.41 lower than Indusry Avg. of 74.55. and higher than S&P 500 Avg. of 0.01

More on AMPH's Valuation

  Market Capitalization (Millions $) 2,293
  Shares Outstanding (Millions) 53
  Employees 2,146
  Revenues (TTM) (Millions $) 638
  Net Income (TTM) (Millions $) 145
  Cash Flow (TTM) (Millions $) 172
  Capital Exp. (TTM) (Millions $) -38
  Total Debt (Millions $) 594
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 297,356
  Net Income/Employee(TTM) $ 67,360
  Receivable Turnover Ratio (TTM) 5.52
  Tangible Book Value (Per Share $) 1.23

  Market Capitalization (Millions $) 2,293
  Shares Outstanding (Millions) 53
  Employees 2,146
  Revenues (TTM) (Millions $) 638
  Net Income (TTM) (Millions $) 145
  Cash Flow (TTM) (Millions $) 172
  Capital Exp. (TTM) (Millions $) -38


    AMPH's Profitability Comparisons
Amphastar Pharmaceuticals Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 27.94 % from 40.25 % in III. Quarter.

Amphastar Pharmaceuticals Inc net profit margin of 25.13 % is currently ranking no. 16 in Major Pharmaceutical Preparations industry, ranking no. 31 in Healthcare sector and number 412 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.18
  Total Debt to Equity (MRQ) 0.88
  Tangible Leverage Ratio (MRQ) 13.81
  Asset Turnover Ratio (TTM) 0.48
  Inventory Turnover Ratio (TTM) 2.7



Amphastar Pharmaceuticals Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 27.94 % from 40.25 % in III. Quarter.

Amphastar Pharmaceuticals Inc net profit margin of 25.13 % is currently ranking no. 16 in Major Pharmaceutical Preparations industry, ranking no. 31 in Healthcare sector and number 412 in S&P 500.

More on AMPH's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com